




idec canadian pharmacy - a new standards of care




































skip to content 





 

menu 




menu 
home
company

history
culture
board of directors
clinician information
business development
who we are
director, marketing
employment information
financial information
community lab
technology
vision, mission and core values
management
our basic principles
careers
strategic alliances


products

what we offer
our process
global engineering & facilities
global quality we make it possible
distribuzione globale


careers

for recruiters
future opportunities


contact us

support groups
locations
disclaimer


investment focus

investor conferences
stock quote


 











idec canadian pharmacy – new standards of care
biogen idec creates new standards of care in therapeutic areas with high unmet medical needs. founded in 1978, biogen idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies.
patients in more than 90 countries benefit from biogen idec’s significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. in 2007, biogen idec’s total revenues grew 18 percent over 2006 to almost $3.2 billion.
learn more about biogen idec.








spotlight 
corporate strategy and goals
product development pipeline
engineering
science
global quality
product development
science
consider biogen idec
contact hr
management
news and media
submit resume


 








 terms and conditions of use | note regarding  forward-looking statements |  privacy policy | site map

 






© 2025 idec pharma  








